Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Lung Diseases 1

Interventions

Carboplatin 202 pembrolizumab 166 Pemetrexed 140 Cisplatin 124 Paclitaxel 77 durvalumab 74 osimertinib 69 Nivolumab 68 Docetaxel 66 Specimen Handling 64 atezolizumab 57 Magnetic Resonance Spectroscopy 53 Etoposide 47 Gemcitabine 46 Radiotherapy 43 Radiosurgery 40 130-nm albumin-bound paclitaxel 34 Drug Therapy 32 Bevacizumab 29 Ipilimumab 28 Cetuximab 27 cemiplimab 25 Taxes 24 tislelizumab 21 Immunoglobulin G 21 Platinum 20 Biopsy 20 amivantamab 19 Radiation 19 Disulfides 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

One-Lung Ventilation × Thoracic × 90 days × Clear all

NCT00534690 2026-05-15

REVOLU

University Hospital, Bordeaux

Phase NA Completed

Lung Diseases, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡